The growing prevalence of sports injuries, elbow tendon bumps, joint pain are the key factors that have urged the advent of the tennis elbow market. In the next few years, the demand for tennis elbow treatment is expected to increase significantly in emerging economies such as China and Canada. In addition, the senior population is growing with the rising global population, and rising sports events are leading to an increase in sports injuries. These are expected to boost the industry in the coming years.
The treatment studies for analyzing the overall lateral epicondylitis market are painkillers and NSAIDs, corticosteroid injections, shock wave therapy surgery, and equipment and other products. Market size and forecast for each of these segments for 2014-2022 are provided in this study, along with respective CAGRs for the forecast period 2016-2022. This report also highlights information about major clinical trial candidates under scrutiny for lateral epicondylitis treatment. These candidates are categorized corresponding to their trial phase, namely phase I, phase II, and phase III.
Geographically, the global lateral epicondylitis market is studied for the following regional markets:
North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Russia
Rest of Europe
Asia-Pacific
India
China
Japan
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC Countries
South Africa
Rest of Middle East and Africa
Market size and forecast for these regional and country-level markets are presented in this study for 2014-2022. Market growth rates for the forecast period 2016-2022 are also included in this report, considering 2015 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global lateral epicondylitis market. Tools such as market positioning of key players and attractive investment propositions provide the readers with insights into the competitive scenario of the global lateral epicondylitis market. This report concludes with a company profiles section that highlights major information about the key players engaged in the lateral epicondylitis market.
Type of Treatment Segmentation Investigation
Based on the type of treatment, the global lateral epicondylitis (tennis elbow) treatment market is segmented as follows:
Painkillers and NSAIDs
Corticosteroid injections
Shock wave therapy
Surgery
Equipment and Other Products
Tennis elbow is a disorder caused due to swelling of the tendons, which leads to pain in the arm and elbow. In addition, the repetitive motion of the arms can lead to a strain on the muscles and tendons; this can further lead to the microscopic tear of the tissues. Several symptoms faced in daily life signal lateral epicondylitis, such as pain in doing the tasks such as lifting something, straightening the wrist or raising the hands, making a grip, etc. Many treatments are available for the conditions, including painkillers and NSAIDs, Corticosteroid injections, shock wave therapy, surgery and equipment, and other products. In the base year 2015, Corticosteroids injection, and Painkillers & NSAIDs accounted for approximately 50% - 55% of the total market share because these are the first-line therapies preferred by medical practitioners, cost-effective and majorly used as supportive therapies, and the most accessible source of treatment across the globe. In addition equipment and other products segment is the largest and most recommended supportive treatment against lateral epicondylitis (tennis elbow).
For this study, the global lateral epicondylitis (tennis elbow) treatment market is categorized as follows:
North America
Europe
Asia Pacific
Latin America (LATAM)
Middle East and Africa (MEA)
The geographical segmentation of the global market for lateral epicondylitis (tennis elbow) treatment market comprises North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. In the base year 2015, North America accounted for the largest market in the lateral epicondylitis (tennis elbow) treatment market due to the rising number of sports competitions & events in U.S. along with the rising awareness among the patients are the key factors contributing toward the growth of lateral epicondylitis treatment market in this region. Tennis elbow is estimated to have a prevalence of 1.3% in the overall population in North America. The incidences mainly occur around the age of 40-50 years. The growing geriatric population in the North American region is also expected to strengthen the demand for lateral epicondylitis treatment. According to market experts, lateral epicondylitis treatment significantly impacts the growth of anti-inflammatory drugs. Anti-inflammatory drugs (NSAIDS) include cortisone, ibuprofen, and aspirin. The data suggests that these are one of the most widely used classes of drugs, with approx. Seventy million subscriptions and over 30 billion over-the-counterover-the-counter tablets are sold annually in the U.S. These drugs are mainly used to control lateral epicondylitis pain.
Frequently asked questions :
The market for Lateral Epicondylitis (Tennis Elbow) Market is expected to reach US$ XX Bn in 2022.
The Lateral Epicondylitis (Tennis Elbow) Market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2016-2022.
The base year of this report is 2015.
ARTHREX, TEIKOKU PHARMA, SEIKAGAKU CORPORATION, UNIPHAR GROUP, SMITH & NEPHEW are some of the major players in the global market.
